Market DispatchesMarket Dispatches

Stocks to watch: Hewlett-Packard, Transatlantic

The computer maker will report quarterly results after the market closes. Alleghany says it will buy Transatlantic Holdings for $3.4 billion.

By TheStreet Staff Nov 21, 2011 8:42AM

TheStreetBy Joseph Woelfel, TheStreet

 

Hewlett-Packard (HPQ) will report fiscal-fourth-quarter earnings after the close Monday. The report will be the first under new CEO Meg Whitman, who joined the company in the middle of the quarter. Analysts expect HP to have earned $1.13 a share on revenue of $32.06 billion.

 

Property and casualty insurer Alleghany (Y) said it will buy reinsurer Transatlantic Holdings (TRH) for $3.4 billion in a cash-and-stock deal. The per-share price of $59.79 is a 10% premium to Transatlantic's Friday closing price of $54.43.

 

Gilead Sciences (GILD) has agreed to buy Pharmasset  (VRUS) for $137 a share in cash in a deal valued at $11 billion. The transaction price is an 89% premium to Pharmasset's Friday closing price of $72.67.

 

Tyson Foods (TSN) said its fiscal-fourth-quarter profit fell to $97 million, or 26 cents a share, from $213 million, or 57 cents, a year earlier. The results fell short of the 32-cent profit analysts surveyed by Thomson Reuters expected.

 

Pfizer (PFE) will pay more than $60 million to settle federal probes into whether it paid bribes to win business outside the U.S., according to The Wall Street Journal. The settlements are expected to be made public by the end of the year, according to the report, published Sunday on the Journal's website. The report cited anonymous sources familiar with the situation.

 

Western Digital (WDC), the producer of computer-storage technology, said an arbitrator in Minnesota has ruled against the company in a dispute with Seagate Technology (STX) and awarded Seagate $525 million plus interest. Western Digital shares were down 1% to $25.59.

 

Earnings are also expected from Analog Devices (ADI) and Brocade Communications (BRCD).

 

Related Articles

 

1Comment
Nov 21, 2011 10:24AM
avatar
With companies like Gilead, Phizer, Merck I was heavily invested in when I was in my 30's but now that I'm in my 60's in many ways I'm regretful of their medical advancements. I should have died many years ago.
Report
Please help us to maintain a healthy and vibrant community by reporting any illegal or inappropriate behavior. If you believe a message violates theCode of Conductplease use this form to notify the moderators. They will investigate your report and take appropriate action. If necessary, they report all illegal activity to the proper authorities.
Categories
100 character limit
Are you sure you want to delete this comment?

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

RECENT QUOTES

WATCHLIST

Symbol
Last
Change
Shares
Quotes delayed at least 15 min
Sponsored by:

MARKET UPDATE

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.

[BRIEFING.COM] The S&P 500 ended this week with a bang, roaring to a new all-time high on the back of stronger-than-expected economic data, influential leadership, and an ongoing appreciation for the Fed's monetary policy support.

The bullish bias was evident in premarket action as the S&P futures pointed to a higher start without the benefit of any definitive news catalyst.  Stocks indeed benefited from a blast of buying interest at the opening bell on this ... More


Currencies

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
Sponsored by:

TOP STOCKS

Scary story: the 2013 market looks like 1987

All hail the bull market, which ended the week with a big rally. But it also is starting to look a little like 1987, which suffered an epic blow-out.

VIDEO ON MSN MONEY